| Phase 1 | 2 | |
| Phase 2 | 1 | |
| Phase 3 | 2 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 3 | ||||
| NCT04975737 | Study of the Safety and Efficacy of the Subunit Recombinant Tuberculosis Vaccine GamTBvac | Tuberculosis | Active, Not Recruiting | 2026-07-06 |
| NCT06815549 | An Open Clinical Trial of the Safety and Efficacy of the Drug Fluorothiazinone, 300 Mg… | P. Aeruginosa | Not Yet Recruiting | 2025-02-07 |
| Phase 2 | ||||
| NCT06135350 | Clinical Trial to Study the Efficacy and Safety of Fluorothiazinone (N.F. Gamaleya NRCEM)… | Gram Negative Pneumonia | Recruiting | 2025-06-24 |
| Phase 1 | ||||
| NCT07184606 | Clinical Study of the Safety and Pharmacokinetics of the Drug Fluorothiazinone, a… | Safety and Pharmacokinetics | Not Yet Recruiting | 2025-09-22 |
| NCT07156864 | "Study of the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and… | COVID-19 | Not Yet Recruiting | 2025-09-05 |
| Not specified | ||||
| NCT06162975 | The Surveillance Clinical Study of Rickettsiosis | Rickettsiosis | Recruiting | 2026-02-19 |